Literature DB >> 15910759

Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats.

Evangelia Spandou1, Zoi Papadopoulou, Vassiliki Soubasi, George Karkavelas, Constantina Simeonidou, Anastasia Pazaiti, Olympia Guiba-Tziampiri.   

Abstract

Perinatal asphyxia accounts for behavioral dysfunctions that often manifest as sensorimotor, learning or memory disabilities throughout development and into maturity. Erythropoietin (Epo) has been shown to exert neuroprotective effects in different models of brain injury including experimental models of perinatal asphyxia. However, the effect of Epo on functional abilities following cerebral hypoxia-ischemia (HI) in neonatal rats is not known. The aim of the present study is to investigate the effect of Epo on sensorimotor deficits and brain injury induced by hypoxia-ischemia. Seven-day-old rats underwent unilateral, permanent carotid artery ligation followed by 1 h of hypoxia. Epo was administered as a single dose immediately after the hypoxic insult (2000 U/kg). The neuroprotective effect of Epo was evaluated at postnatal day 42 by using a battery of behavioral tests and histological analysis. The results of the present study suggest that Epo treatment immediately after HI insult significantly facilitated recovery of sensorimotor function. Consistently, histopathological evaluation demonstrated that Epo significantly attenuated brain injury and preserved the integrity of cerebral cortex. These findings indicate that long-term neuroprotective effect of Epo on neonatal HI-induced brain injury might be associated with the preservation of sensorimotor functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15910759     DOI: 10.1016/j.brainres.2005.03.013

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

1.  Mobilization of circulating progenitor cells following brain injury in premature neonates could be indicative of an endogenous repair process. A pilot study.

Authors:  N Efstathiou; V Soubasi; G Koliakos; G Kyriazis; D I Zafeiriou; A Slavakis; K Kantziou; T Pozotou; O Chatzizisi; V Drosou-Agakidou
Journal:  Hippokratia       Date:  2015 Apr-Jun       Impact factor: 0.471

2.  Hypoxic Ischemic Encephalopathy: Pathophysiology and Experimental Treatments.

Authors:  Kimberly A Allen; Debra H Brandon
Journal:  Newborn Infant Nurs Rev       Date:  2011-09-01

3.  Long-term evaluation of granulocyte-colony stimulating factor on hypoxic-ischemic brain damage in infant rats.

Authors:  Nancy Fathali; Tim Lekic; John H Zhang; Jiping Tang
Journal:  Intensive Care Med       Date:  2010-05-12       Impact factor: 17.440

4.  Neuroprotective Effect of Erythropoietin on Phenylhydrazine-Induced Hemolytic Hyperbilirubinemia in Neonatal Rats.

Authors:  Asli Memisoglu; Meltem Kolgazi; Akan Yaman; Elif Bahadir; Serap Sirvanci; Berrak Ç Yeğen; Eren Ozek
Journal:  Neurochem Res       Date:  2016-12-19       Impact factor: 3.996

5.  Granulocyte colony-stimulating factor activating HIF-1alpha acts synergistically with erythropoietin to promote tissue plasticity.

Authors:  Shih-Ping Liu; Shin-Da Lee; Hsu-Tung Lee; Demeral David Liu; Hsiao-Jung Wang; Ren-Shyan Liu; Shinn-Zong Lin; Ching-Yuan Su; Hung Li; Woei-Cherng Shyu
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

6.  Erythropoietin: a multimodal neuroprotective agent.

Authors:  Nadiya Byts; Anna-Leena Sirén
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

7.  Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor.

Authors:  Ye Xiong; Asim Mahmood; Changsheng Qu; Humaira Kazmi; Zheng Gang Zhang; Constance T Noguchi; Timothy Schallert; Michael Chopp
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

8.  Anti-neutrophil antibody enhances the neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model.

Authors:  Desislava M Doycheva; Tiffany Hadley; Li Li; Richard L Applegate; John H Zhang; Jiping Tang
Journal:  Neurobiol Dis       Date:  2014-05-27       Impact factor: 5.996

Review 9.  Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.

Authors:  Anna-Leena Sirén; Theresa Fasshauer; Claudia Bartels; Hannelore Ehrenreich
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

10.  Granulocyte-colony stimulating factor in combination with stem cell factor confers greater neuroprotection after hypoxic-ischemic brain damage in the neonatal rats than a solitary treatment.

Authors:  Desislava Doycheva; Gary Shih; Hank Chen; Richard Applegate; John H Zhang; Jiping Tang
Journal:  Transl Stroke Res       Date:  2012-11-08       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.